| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-21 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |